{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:02:08Z","timestamp":1791180128994,"version":"4.1.0"},"reference-count":25,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":4435,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified tissue inhibitor of metalloproteinase 3 (TIMP3), the endogenous inhibitor of A disintegrin and metalloprotease domain 17 (ADAM17) and other matrix metalloproteinases (MMPs), as a gene modifier for insulin resistance and vascular inflammation in mice. We tested its association with atherosclerosis in subjects with type 2 diabetes and identified Sirtuin 1 (SirT1) as a major regulator of TIMP3 expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We investigated ADAM10, ADAM17, MMP9, TIMP1, TIMP2, TIMP3, and TIMP4 expression levels in human carotid atherosclerotic plaques (n = 60) from subjects with and without diabetes. Human vascular smooth muscle cells exposed to several metabolic stimuli were used to identify regulators of TIMP3 expression. SirT1 small interference RNA, cDNA, and TIMP3 promoter gene reporter were used to study SirT1-dependent regulation of TIMP3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Here, we show that in human carotid atherosclerotic plaques, TIMP3 was significantly reduced in subjects with type 2 diabetes, leading to ADAM17 and MMP9 overactivity. Reduced expression of TIMP3 was associated in vivo with SirT1 levels. In smooth muscle cells, inhibition of SirT1 activity and levels reduced TIMP3 expression, whereas SirT1 overexpression increased TIMP3 promoter activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>In atherosclerotic plaques from subjects with type 2 diabetes, the deregulation of ADAM17 and MMP9 activities is related to inadequate expression of TIMP3 via SirT1. Studies in vascular cells confirmed the role of SirT1 in tuning TIMP3 expression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db09-0280","type":"journal-article","created":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T01:28:50Z","timestamp":1246930130000},"page":"2396-2401","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":129,"title":["TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1"],"prefix":"10.2337","volume":"58","author":[{"given":"Marina","family":"Cardellini","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Menghini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Martelli","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Casagrande","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Marino","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rizza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Porzio","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mauriello","sequence":"additional","affiliation":[{"name":"Department of Biopathology and Diagnostic Imaging, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Solini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Ippoliti","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Lauro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Folli","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2009,7,6]]},"reference":[{"key":"2022031208061575500_B1","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"2022031208061575500_B2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.RES.0000259589.34348.74","article-title":"Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?","volume":"100","author":"Kanter","year":"2007","journal-title":"Circ Res"},{"key":"2022031208061575500_B3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hh1201.092042","article-title":"Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress","volume":"88","author":"Uemura","year":"2001","journal-title":"Circ Res"},{"key":"2022031208061575500_B4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.0000023043.02648.51","article-title":"Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells","volume":"106","author":"Federici","year":"2002","journal-title":"Circulation"},{"key":"2022031208061575500_B5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.RES.0000232352.90786.fa","article-title":"Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature","volume":"99","author":"Chung","year":"2006","journal-title":"Circ Res"},{"key":"2022031208061575500_B6","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1172\/JCI26052","article-title":"TIMP3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha","volume":"115","author":"Federici","year":"2005","journal-title":"J Clin Invest"},{"key":"2022031208061575500_B7","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2337\/db07-0360","article-title":"Mice heterozygous for tumor necrosis factor-\u03b1 converting enzyme are protected from obesity-induced insulin resistance and diabetes","volume":"56","author":"Serino","year":"2007","journal-title":"Diabetes"},{"key":"2022031208061575500_B8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.gastro.2008.10.079","article-title":"Tissue Inhibitor of Metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice","volume":"136","author":"Menghini","year":"2009","journal-title":"Gastroenterology"},{"key":"2022031208061575500_B9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1194\/jlr.M800053-JLR200","article-title":"Candidate genes for plasma triglyceride, free fatty acid, and glucose revealed from an intercross between inbred mouse strains NZB\/B1NJ x NZW\/LacJ","volume":"49","author":"Su","year":"2008","journal-title":"J Lipid Res"},{"key":"2022031208061575500_B10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00125-007-0768-z","article-title":"Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes","volume":"50","author":"Barth","year":"2007","journal-title":"Diabetologia"},{"key":"2022031208061575500_B11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2007.10.009","article-title":"Clipping, shedding and RIPping keep immunity on cue","volume":"29","author":"Murphy","year":"2008","journal-title":"Trends Immunol"},{"key":"2022031208061575500_B12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2007.10.003","article-title":"DisSIRTing on LXR and cholesterol metabolism","volume":"6","author":"Feige","year":"2007","journal-title":"Cell Metab"},{"key":"2022031208061575500_B13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab"},{"key":"2022031208061575500_B14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2008.08.014","article-title":"SirT1 gain of function increases energy efficiency and prevents diabetes in mice","volume":"8","author":"Banks","year":"2008","journal-title":"Cell Metab"},{"key":"2022031208061575500_B15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/cvr\/cvn224","article-title":"Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice","volume":"80","author":"Zhang","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2022031208061575500_B16","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00125-008-1127-4","article-title":"Effects of different LDL particles on inflammatory molecules in human mesangial cells","volume":"51","author":"Santini","year":"2008","journal-title":"Diabetologia"},{"key":"2022031208061575500_B17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cmet.2005.04.005","article-title":"Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha","volume":"1","author":"Lehrke","year":"2005","journal-title":"Cell Metab"},{"key":"2022031208061575500_B18","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1073\/pnas.0709805104","article-title":"Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17","volume":"104","author":"Chen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031208061575500_B19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/en.2008-0677","article-title":"Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-{alpha} via protein kinase C-{delta} and TNF-{alpha} converting enzyme in vascular smooth muscle cells","volume":"150","author":"Reddy","year":"2009","journal-title":"Endocrinology"},{"key":"2022031208061575500_B20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2796.2008.01965.x","article-title":"The molecular mechanisms of the thrombotic complications of atherosclerosis","volume":"263","author":"Libby","year":"2008","journal-title":"J Intern Med"},{"key":"2022031208061575500_B21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1189\/jlb.0106038","article-title":"Emerging roles for ectodomain shedding in the regulation of inflammatory responses","volume":"79","author":"Garton","year":"2006","journal-title":"J Leukoc Biol"},{"key":"2022031208061575500_B22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.RES.83.3.270","article-title":"Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability","volume":"83","author":"Fabunmi","year":"1998","journal-title":"Circ Res"},{"key":"2022031208061575500_B23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/db07-1261","article-title":"In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta","volume":"57","author":"Boden","year":"2008","journal-title":"Diabetes"},{"key":"2022031208061575500_B24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCRESAHA.107.168369","article-title":"Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging","volume":"102","author":"Ungvari","year":"2008","journal-title":"Circ Res"},{"key":"2022031208061575500_B25","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1210\/en.2006-0167","article-title":"FOXO1A differentially regulates genes of decidualization","volume":"147","author":"Buzzio","year":"2006","journal-title":"Endocrinology"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/58\/10\/2396\/666548\/zdb01009002396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/58\/10\/2396\/666548\/zdb01009002396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:19:02Z","timestamp":1667405942000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/58\/10\/2396\/13276\/TIMP3-Is-Reduced-in-Atherosclerotic-Plaques-From"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,6]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,7,6]]},"published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db09-0280","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,6]]}}}